 |
These partnerships fall into three types:
Contracted out services
The company has contracted out to the following industry providers: NuPharm Laboratories, Materia Medica, Constella Group Inc, Origin Pharmaceutical Services Ltd and Oxford Therapeutics Consulting. Experienced consultants are employed to assist and advise the company.
Academic collaborations
The company has an established network of academic collaborations to expand the understanding of the mode of action of CMP and to investigate new applications of CMP in fighting disease. The list of academic collaborations includes: The National Institute for Infectious Diseases in Tokyo, Japan; Paediatric Allergy and Immunology Division, Marmara University, Istanbul, Turkey; The Telethon Institute for Child Health Research, University Western Australia; The Faculty of Public Health, Mahidol University, Bangkok, Thailand; The Edward Jenner Institute for Vaccine Research, Compton, UK; The National Institute for Medical Research, London.
Pharmaceutical industry partnerships
The company seeks partners from the pharmaceutical industry to advance the further development and commercialisation of CMP in each of its major indications. These are: allergic rhinitis, adjuvant for allergen specific desensitization, anti-infective, including prophylaxis against influenza and human rhinovirus and as a vaccine adjuvant for mucosal vaccines.
|
|
|
|
|
